Barclays upgrades Givaudan stock rating on operational resilience
Barclays upgraded Givaudan SA's stock rating to "Overweight" on Monday, reflecting the bank's increased confidence in the specialty chemicals company's operational resilience. The investment firm raised its price target to CHF3,850.00 from the previous CHF3,450.00. Despite the specialty chemicals sector's premium valuations, Barclays downgraded Givaudan to "Equalweight" in March due to concerns over Middle East disruptions, rising oil prices, higher raw material costs, and underperformance in the Taste & Wellbeing segment.
However, Givaudan has proven more resilient than initially anticipated. The company's raw material inflation within the second half of the current fiscal year has contracted to low-single-digit levels, and management continues to guide to flat margins in 2026, even with higher oil prices. Givaudan maintains a healthy gross profit margin of 43.7%.
While InvestingPro data indicates the stock is slightly overvalued relative to its fair value, the operational resilience of the company has reduced the downside risk Barclays initially viewed. Barclays' forecasts for 2027 incorporate some gross margin pressure due to elevated oil prices and the potential for El Niño to drive higher inflation in natural materials.
However, the firm believes this will be offset by favorable mix, stronger pricing, and continued cost discipline. JPMorgan recently reiterated its "Overweight" rating on Givaudan SA, maintaining a price target of CHF3,600.00, following the firm's attendance at the company's annual summer conference in Zurich. Givaudan's new CEO, Christian Stammkoetter, shared insights into the company's strategic plan for 2030, which includes 4-6% organic sales growth and a free cash flow margin exceeding 12%.
This strategic focus aligns with Givaudan's long-term planning, emphasizing purpose-linked targets. The reiteration by JPMorgan suggests increased confidence in Givaudan's strategic direction and financial goals, which may be of interest to investors evaluating their positions.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.